Opioid QuOTA Act of 2021

Hozzl · 2022-12-30T03:18:55Z

Explore the details of Senate Bill 3327 Opioid QuOTA Act of 2021 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Crime and Law Enforcement. Stay informed on legislative developments.

12/30/2022, 3:18 AM

Congressional Summary of S 3327

Opioid Quota Openness, Transparency, and Awareness Act of 2021 or the Opioid QuOTA Act of 2021

This bill requires the Drug Enforcement Administration to make publicly available on its website certain information regarding opioid procurement quotas.

The term opioid procurement quota means the maximum quantity of opioid analgesics that a registered manufacturer may procure.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 3327

Bill S 3327 is currently in the status of Bill Introduced since December 7, 2021. Bill S 3327 was introduced during Congress 117 and was introduced to the Senate on December 7, 2021. Bill S 3327's most recent activity was Read twice and referred to the Committee on the Judiciary. as of December 7, 2021

Bipartisan Support of Bill S 3327

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 3327

Primary Policy Focus

Crime and Law Enforcement

Potential Impact Areas

- Government Operations and Politics

Alternate Title(s) of Bill S 3327

Opioid QuOTA Act of 2021

Opioid Quota Openness, Transparency, and Awareness Act of 2021

A bill to amend the Controlled Substances Act to require the Attorney General to make procurement quotas for opioid analgesics publicly available, and for other purposes.